Recall Record

Saint Paul, MN, United States

Fagron, Inc recalls

5 recalls recorded since 2018, most recently on 11 December 2023. 1 is listed as ongoing. Status and classification are as published by the FDA.

Recalls5
Ongoing (FDA)1
Terminated or completed4
Class I (FDA)1

Ongoing Class II Drugs

Recall started
11 December 2023
Reason
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.
Distribution
Product was distributed to 1 distributor and may have further distributed the product to repacker/relabelers and pharmacies in the United States and Canada to be used for prescription compounding.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0154-2024, D-0155-2024, D-0156-2024, D-0157-2024

Terminated Class III Drugs

Recall started
4 March 2022
Terminated
14 July 2024
Reason
Subpotent Drug
Distribution
Nationwide within the USA
Initiated
Voluntary: Firm initiated
Recall numbers
D-0864-2022, D-0865-2022, D-0862-2022, D-0863-2022, D-0866-2022

Completed Class I Drugs

Recall started
4 March 2022
Reason
Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli.
Distribution
Nationwide USA and Puerto Rico, Canada, Columbia, France
Initiated
Voluntary: Firm initiated
Recall number
D-0856-2022

Terminated Class II Drugs

Recall started
31 October 2019
Terminated
6 November 2020
Reason
Microbial contamination of non-sterile product.
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0533-2020

Terminated Class II Drugs

Recall started
14 February 2018
Terminated
10 September 2019
Reason
Microbial contamination of Non-Sterile Product; product contamination with yeast and mold (Paecilomyces saturatus and Aspergillus fumigatus).
Distribution
Nationwide, USA
Initiated
Voluntary: Firm initiated
Recall number
D-0547-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.